Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Journal of Pediatric Surgery|March 25, 2021
PIM447 inhibits oncogenesis and potentiates cisplatin effects in hepatoblastomaNikita Wadhwani, Hooper R Markert, Raoud Marayati, et al.Cancer Immunology, Immunotherapy : CII|September 5, 2024
Oncolytic virotherapy augments self-maintaining natural killer cell line cytotoxicity against neuroblastomaColin H Quinn, Janet R Julson, Hooper R Markert, et al.Journal of Pediatric Surgery|March 25, 2021
Novel second-generation rexinoid induces growth arrest and reduces cancer cell stemness in human neuroblastoma patient-derived xenograftsRaoud Marayati, Laura V Bownes, Colin H Quinn, et al.Scientific Reports|April 17, 2025
Investigation of an oncolytic herpes simplex virus as a potential therapeutic agent for gastroenteropancreatic neuroendocrine neoplasmsColin H Quinn, Janet R Julson, Michael H Erwin, et al.Cancer Gene Therapy|April 17, 2021
CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cellsRaoud Marayati, Laura L Stafman, Adele P Williams, et al.ACS Omega|September 19, 2022
Rapid Characterization of Solid Tumors Using Resonant SensorsAndee M Beierle, Colin H Quinn, Hooper R Markert, et al.Scientific Reports|September 15, 2019
Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived XenograftsLaura L Stafman, Adele P Williams, Raoud Marayati, et al.Cancers|November 27, 2024
Novel PP2A-Activating Compounds in NeuroblastomaNazia Nazam, Laura V Bownes, Janet R Julson, et al.Journal of Pediatric Surgery|March 12, 2023
The Effects of Protein Phosphatase 2A Activation with Novel Tricyclic Sulfonamides on HepatoblastomaLaura V Bownes, Janet R Julson, Colin H Quinn, et al.Translational Oncology|April 22, 2021
Downregulation of PDGFRß Signaling Overcomes Crizotinib Resistance in a TYRO3 and ALK Mutated Neuroendocrine-Like TumorColin H Quinn, Andee M Beierle, Adele P Williams, et al.Pageof 2